UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event report): March 10, 2006 AMS HEALTH SCIENCES, INC. ------------------------- (Exact name of registrant as specified in its charter) OKLAHOMA 001-13343 73-1323256 -------- --------- ---------- (State or other (Commission File (IRS Employer jurisdiction of Number) Identification incorporation) Number) 711 NE 39th Street, Oklahoma City, OK 73105 ------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (405) 842-0131 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Information to be Included in the Report Item 5.02. Departure of Directors or Principal Officers; Election of Directors Appointment of Principal Officers. On March 10, 2006, AMS Health Sciences, Inc. (AMEX: AMM) announced that the Board of Directors had approved the appointment of Stephen E. Jones as an independent director of the Company. Mr. Jones was appointed to fill the vacancy left by the resignation of Brent Haggard in January 2006. Mr. Jones has been appointed to serve on the audit and compensation committees of the board of directors. Item 9.01. Financial Statements and Exhibits (c) Exhibits 99.1 Press release dated March 10, 2006 SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized. AMS HEALTH SCIENCES, INC. JERRY W. GRIZZLE By: Jerry W. Grizzle Chairman, President and Chief Executive Officer Date: March 17, 2006 EXHIBIT INDEX Exhibit No. Description Method of Filing --- ----------- ---------------- 99.1 Press release dated March 17, 2006 Filed herewith electronically